Taxotere Permanent Hair Loss Lawsuits
Taxotere (docetaxel) is a chemotherapy drug manufactured by Sanofi Aventis and used in the treatment of breast cancer, lung cancer, prostate cancer, stomach cancer and head & neck cancer. It works by interfering with the growth of cancer cells.
Taxotere associated with permanent hair loss
The FDA issued a safety announcement in December 2015 for Taxotere citing a number of adverse event reports of permanent alopecia or hair loss. Many patients undergoing chemotherapy treatments for cancer are told of a possible temporary hair loss, however, patients undergoing chemotherapy treatment with Taxotere were unaware of the potential for permanent hair loss. This can be particularly devastating to women. Permanent hair loss can have a significant psychological impact on patients.
In 2013, researchers gathered data from patients who received chemotherapy treatment using Taxotere during 2010. Findings of the survey data indicated 15% of respondents experienced significant persistent scalp hair loss. Patient advocate organization A Head of Our Time reported a study conducted by Dr. Scot Sedlacek, an oncologist at the Rocky Mountain Cancer Centers in Denver, Colorado conducted a study in 2006 that found as many as 6% of his study group who received Taxotere in chemotherapy treatment experienced permanent hair loss or alopecia.
Taxotere hair loss lawsuits
Permanent hair loss can have a devastating psychological impact on chemotherapy patients. It can stand as a life-long reminder of cancer and negatively impact self-esteem as well as contribute to depression and other mental health issues. Many patients who experience Taxotere alopecia claim Sanofi Aventis failed to warn them and their healthcare providers that permanent hair loss could occur if they are prescribed Taxotere for chemotherapy treatment of cancer.
Cohen & Malad, LLP product liability attorneys are interested in talking with people who have taken Taxotere and suffered permanent alopecia. Our attorneys have litigated hundreds of claims against large pharmaceutical companies and medical device manufacturers. Contact us for a free case evaluation.
